Open company graph database — free web & API
Login

Shanghai Dongfulong Biological Reagents Co., Ltd.

上海东富龙生物试剂有限公司上海東富龍生物試薬有限公司Alias
Ticker
—
Listed market
—
Country
China
Employees (non-consolidated)
—
Related companies
2
§01

Basic information

BASIC
Head office
Chief executive
Employees (non-consolidated)
Employees (consolidated)
Start date
2021-01-01
End date
§02

Websites

1 DOMAINS
§03

Business

33
Cell therapy process developmentSourcesSourcesLarge molecule drug process developmentSourcesSourcesCustom commercial culture medium developmentSourcesSourcesAntibody production system solutionsSourcesSourcesCGT production system solutionsSourcesSourcesVaccine production system solutionsSourcesSourcesKey reagent R&D and productionSourcesFlow cytometerSourcesGMP cell drug preparation full station systemSourcesCell culture mediumSourcesDry powder culture mediumSourcesCell gene therapy productsSourcesLarge molecule drug productsSourcesKey reagent supply for life science research and biotechnology industrySourcesLarge molecule drug (antibody/protein/vaccine) culture medium seriesSourcesSerum-free culture medium for cell and gene therapySourcesCytokines for cell and gene therapy induction stimulationSourcesCryopreservation solution for cell and gene therapySourcesDisposable bioreactorsSourcesSerum-free medium for T lymphocyte cultureSourcesNK Cell Serum-Free Culture Medium KitSourcesMesenchymal Stem Cell Serum-Free MediumSourcesCell Storage SolutionSourcesE. coli Limited Chemical Component MediumSourcesHEK293 Series MediumSourcesCHO Series MediumSourcesTobitec Series Supplement MediumSourcesInsect Serum-Free MediumSourcesBHK Serum-Free MediumSourcesVero Serum-Free MediumSourcesMDCK Serum-Free MediumSourcesBasic MediumSourcesLMH SFM01 Serum-Free MediumSources
§04

Related companies

2 COMPANIES
Company name Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
上海东富龙医疗科技产业发展有限公司
Group Parent
Dongfu Long Technology Group Co., Ltd. Sources
Group Subsidiary
Names without a link are companies not yet registered in OpenBizGraph
§05

Network

NETWORK
Drag to move · click to open
§06

History

9 EVENTS

Establishment of Shanghai Dongfulong Medical Technology Industry Development Co., Ltd.; Development of systematic solutions for large-molecule drugs and cell therapy.Sources

Acquisition of a CAR-T company focused on cell drug process R&D; establishment of a biological cell laboratory and research on cell culture technology; creation of a GMP demonstration center for cell drug conversion public service platform; establishment of a dedicated department for medium R&D and production under the life science division; construction of a medium R&D and pilot production laboratory for formulation research.Sources

Founded in 2021, Dongfulong Biological Reagents is a wholly-owned subsidiary of Dongfulong Technology Group Co., Ltd. It focuses on life science research and biotechnology industry, aiming to build an integrated domestic bioreagent R&D, application transformation, and industrial production and sales platform, providing comprehensive support for key reagents and overall domestic solutions.Sources

Established Shanghai Dongfulong Biological Reagents Co., Ltd. in April 2021.Sources

Established Shanghai Dongfulong Biological Reagents Co., Ltd. in April 2021.Sources

ISO9001:2015 quality system certification obtained in December 2021.Sources

ISO9001:2015 quality system certification obtained in December 2021; launched systematic commercial medium products for large-molecule drugs and cell therapy; achieved international and domestic market launch and promotion of proprietary medium products.Sources

Technical breakthrough: Development and production of CHO, HEK293 series product formulations. Production capacity breakthrough: Establishment of a scaled-up production line (Hangzhou Medical Town). Performance breakthrough: Achieved international supply chain for domestically produced culture media. Certification documents: DMF registration filing (CHO, HEK293).Sources

Awarded Shanghai Municipal Science and Technology Small and Medium Enterprise, awarded Shanghai Municipal High-tech Enterprise, T-cell serum-free medium, Vero cell serum-free medium, and cell preservation solution received FDA DMF registration filing in the United States.Sources

§07

News

0 ARTICLES

There is no news.

§09

Sources & updates

SOURCES
↑